Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.75
-0.28 (-3.10%)
At close: Jul 31, 2026, 4:00 PM EDT
8.74
-0.01 (-0.11%)
After-hours: Jul 31, 2026, 7:58 PM EDT
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $695.01 million as of July 31, 2026. Its market cap has increased by 14.30% in one year.
Market Cap
695.01M
Enterprise Value
1.06B
1-Year Change
14.30%
Ranking
Category
Stock Price
$8.75
ChartMarket Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $695.01M, an increase of 31.85%. That is a compound annual growth rate of 4.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 695.01M | -41.11% |
| Dec 31, 2025 | 1.18B | 112.56% |
| Dec 31, 2024 | 555.22M | 6.22% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 761.35M |
| Aura Biosciences | 755.55M |
| Tenax Therapeutics | 750.54M |
| Faeth Therapeutics | 747.33M |
| SpyGlass Pharma | 745.56M |
| Monopar Therapeutics | 744.10M |
| Bright Minds Biosciences | 731.41M |
| Candel Therapeutics | 720.98M |